RedCrow Backed MindChild Successfully Receives FDA Approval

RedCrow, the innovative equity crowdfunding platform encouraging accredited and non-accredited investors initially helping health care and medtech startups grow, announced that MindChild Medical successfully received FDA approval for a non-invasive fetal heart monitor. The RedCrow-backed company submitted a 510(k) in 2012 for its MERIDIAN M110 monitor, a medical marvel measuring and displaying fetal heart rate (FHR), […]

RedCrow, the innovative equity crowdfunding platform encouraging accredited and non-accredited investors initially helping health care and medtech startups grow, announced that MindChild Medical successfully received FDA approval for a non-invasive fetal heart monitor. The RedCrow-backed company submitted a 510(k) in 2012 for its MERIDIAN M110 monitor, a medical marvel measuring and displaying fetal heart rate (FHR), maternal heart rate (MHR), and uterine contractions (UA). The device, which has the potential to save thousands of lives, is one of projects RedCrow has helped support, and further, enabled others to help support.

MindChild, a privately funded medical device company launched in 2008, inspired the founding of RedCrow. CEO and founder of RedCrow, Brian Smith, became immersed with the development of MindChild following a personal tragedy that he and his wife experienced in 2003, when their first child was born prematurely and passed away shortly after birth. While working as a financial advisor at Morgan Stanley, Smith discovered that MindChild had the capabilities to save lives like his daughter’s with their breakthrough fetal monitor. It then became evident to Brian that there was a treasure chest of other startups that could do the same and he wanted to help generate awareness for these companies while simultaneously helping them raise funds. The idea blossomed into what is now RedCrow, and after a meeting of the minds with Chairman Jerry Harrison, they carefully vetted their first portfolio of companies, focused purely on improving lives, MiRTLE MedicalIXCELA and Stretch, officially launching RedCrow in November 2016.

“We are ecstatic MindChild’s fetal heart monitor received FDA approval. It was several years in the making but it’s a massive achievement for MindChild, and for RedCrow. We now have proven ability to facilitate significant governmental approval for groundbreaking products in the medtech and healthcare sectors, paving the way for other featured companies on our platform to reach their full potential,” said Brian Smith, CEO of RedCrow.

“Being involved with MindChild from infancy to present-day is extremely rewarding. I am grateful to have been a small part of their growth and I know that others who have experienced tragedies like my own are equally as proud,” Smith continued.

Bill Edelman, CEO of MindChild stated, “We are thrilled to have reached this milestone. The MERIDIAN M110 Fetal Monitoring System is the latest in a series of non-invasive fetal monitor technologies developed by MindChild that are intended to provide the healthcare community enhanced monitoring capabilities for both fetal heart rate, maternal heart rate and uterine contraction, with a single set of disposable abdominal surface electrodes. The MERIDIAN M110 has the potential to provide essential fetal monitoring, replacing four separate monitoring technologies now in use world-wide. We anticipate significant clinical interest for this innovative technology in the markets where MERIDIAN will be cleared for commercial distribution.”

“We have initially focused on the healthcare and medtech verticals for RedCrow because that’s what we truly care about, and there is so much innovation in this space that deserves attention, and subsequent funding. Our mission at RedCrow is to discover and help investors discover privately held, early stage startups that seek to make a positive social impact. At the end of the day, if we are vetting companies that have the potential to save many lives, like MindChild, we have done our job well,” Smith said.

The MERIDIAN M110 Fetal Monitoring System can be used on women who are either in labor or who are at the minimum of 37 completed weeks. The monitor is also indicated for use with singleton pregnancies using surface electrodes on the maternal abdomen. The MERIDIAN M110 Fetal Monitoring System is intended for use by health care professionals in a clinical setting.

Read this next

Industry News

The B2Broker B2Core REST API Is Now Live

B2Broker has announced the release of its new REST API, which lets customers use B2Broker’s solutions and services for business purposes.

Executive Moves

CME Group taps Paul Woolman to lead Equity Index, Giovanni Vicioso to lead Crypto

“Our equity and cryptocurrency businesses have experienced tremendous growth in recent years, underpinned by strong customer adoption and continued innovation.”

Technology

Sumsub launches document-free KYC for users in India, Brazil, Nigeria and Indonesia

Sumsub has launched one click-KYC for users in India, Brazil, Nigeria and Indonesia in a move that allows businesses to instantly onboard over 2 billion users without requesting their ID documents.

Digital Assets

Cboe becomes first major global exchange operator on DeFi data platform, Pyth Network

“Our participation in the Pyth network will provide another avenue to broaden customer access to our data, and aligns with our strategy to deliver market data to investors around the globe based on how they want to consume their data, whether through direct connectivity methods, the cloud or the blockchain.”

Industry News

FINRA fines Barclays Capital $2 million for best execution failures for 5 years

FINRA has fined Barclays Capital $2 million for failing to comply with its best execution obligations in connection with its customers’ electronic equity orders between January 2014 and February 2019. 

Digital Assets

SETL helps SWIFT, CSDs and custodians develop common framework for tokenisation systems

London-based enterprise DLT and blockchain company SETL has delivered a pilot project for SWIFT which implemented a common framework linking tokenisation systems between central security depositories (CSDs) and global custodians.

Digital Assets

Crypto volumes hit CHF 87.1 million at Switzerland exchange

Switzerland’s principal exchange has experienced a rebound in trading activities for September 2022, with monthly volumes increasing by more than 20 percent MoM.

Digital Assets

Bitcoin Suisse Vault taps Polkadot governance features

Bitcoin Suisse has added support for Polkadot protocol governance on its proprietary, hyper-secure cold storage solution, the Bitcoin Suisse Vault.

Retail FX

Finalto sweetens offering for African traders with localized FX pairs

Finalto, the financial trading division of Gopher Investments, announced today that it has extended its offering with inclusion of a number of African Pairs to its trading platforms.

<